Risk of cardiovascular toxicity with combination of immune-checkpoint inhibitors and angiogenesis inhibitors: a meta-analysis

IntroductionCombinations of immune checkpoint inhibitors (ICIs) and angiogenesis inhibitors (AIs) have been investigated for the treatment of several tumor types. Both ICIs and AIs may lead to cardiovascular adverse events, and their combination may potentially increase the risk for cardiovascular t...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Alessandro Inno, Antonello Veccia, Giorgio Madonia, Alvise Berti, Roberto Bortolotti, Lorena Incorvaia, Antonio Russo, Orazio Caffo, Stefania Gori
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2024-02-01
Colecção:	Frontiers in Cardiovascular Medicine
Assuntos:	immune checkpoint inhibitors angiogenesis inhibitors multikinase inhibitors cardiovascular toxicity hypertension stroke
Acesso em linha:	https://www.frontiersin.org/articles/10.3389/fcvm.2024.1309100/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!